Get started
Author

Evan D. Buckley

Observed names: E Buckley, E.D. Buckley, Evan Buckley, Evan D Buckley
OpenAlex ID: A5073777874
Recombinant polio–rhinovirus immunotherapy for recurrent paediatric high-grade glioma: a phase 1b trial
2023 · Eric M Thompson, Daniel Landi, et al. · The Lancet Child & Adolescent Health · 49
Outcomes in Patients With 4 to 10 Brain Metastases Treated With Dose-Adapted Single-Isocenter Multitarget Stereotactic Radiosurgery: A Prospective Study
2021 · Grace J. Kim, Evan D. Buckley, et al. · Advances in Radiation Oncology · 24
A peptide vaccine targeting the CMV antigen pp65 in children and young adults with recurrent high-grade glioma and medulloblastoma: a phase 1 trial
2025 · Eric M. Thompson, David M. Ashley, et al. · Nature Cancer · 16
Systemic Therapy Type and Timing Effects on Radiation Necrosis Risk in HER2+ Breast Cancer Brain Metastases Patients Treated With Stereotactic Radiosurgery
2022 · Christine Park, Evan D. Buckley, et al. · Frontiers in Oncology · 12
PDF
Outcomes In Patients With 4-10 Brain Metastases Treated With Dose-Adapted Single-Isocenter Multitarget Stereotactic Radiosurgery: A Prospective Study
2020 · G.J. Kim, E.D. Buckley, et al. · International Journal of Radiation Oncology*Biology*Physics · 12
Ltbk-09. Results of Bmx-hgg Study: a Multi-institutional, Randomized Phase 2 Clinical Trial of Concurrent Chemoradiation With or Without Bmx-001 in Patients With Newly Diagnosed High Grade Glioma
2023 · Katherine Peters, Adam Cohen, et al. · Neuro-Oncology · 9
PDF
CTIM-21. PEPTIDE VACCINE DIRECTED TO CMV pp65 FOR TREATMENT OF RECURRENT MALIGNANT GLIOMA AND MEDULLOBLASTOMA IN CHILDREN AND YOUNG ADULTS: PRELIMINARY RESULTS OF A PHASE I TRIAL
2020 · Eric Thompson, Daniel Landi, et al. · Neuro-Oncology · 7
Outcomes and immune response after peptide vaccination targeting human cytomegalovirus antigen pp65 in children and young adults with recurrent high-grade glioma and medulloblastoma.
2024 · Eric Thompson, David M. Ashley, et al. · Journal of Clinical Oncology · 5
PDF
Primary brain tumor patients admitted to a US intensive care unit: a descriptive analysis
2021 · Jennifer H Kang, Christa B Swisher, et al. · CNS Oncology · 5
A surgical window of opportunity trial evaluating the effect of the PCSK9 inhibitor evolocumab on tumoral MHC-I expression and CD8+ infiltration in glioma
2025 · Kirit Singh, Matthew W. Foster, et al. · Scientific Reports · 4
PDF
Financial toxicity of oral chemotherapy in patients with primary brain tumors
2024 · Mallika P Patel, Mary Lou Affronti, et al. · Neuro-Oncology Practice · 3
Combination checkpoint blockade and laser interstitial thermal therapy in radiographically progressive non-small cell lung cancer brain metastases
2024 · Aden P Haskell-Mendoza, Ethan S Srinivasan, et al. · Neuro-Oncology Advances · 3
Epct-01. a Novel Peptide Vaccine Directed to Cmv Pp65 for Treatment of Recurrent Malignant Glioma and Medulloblastoma in Children and Young Adults: Preliminary Results of a Phase I Trial
2021 · Eric Thompson, Daniel Landi, et al. · Neuro-Oncology · 3
Ncog-43. a Retrospective Analysis of the Impact of the Covid-19 Infection on Neuro-oncology Care and Patient Outcomes: a Two-site Study
2022 · Margaret Johnson, Jennifer Durling, et al. · Neuro-Oncology · 1
Qolp-20. a Feasibility Study Utilizing Mindfulness Meditation During Concomitant Chemoradiation in Malignant Glioma Patients: Health-reported Quality of Life (hrqol) Results
2020 · Dina Randazzo, Evan Buckley, et al. · Neuro-Oncology · 1
PDF
A universal CD4 epitope enhances cytotoxic T-cell priming and memory in glioblastoma peptide vaccination 2257077
2026 · Kelly Hotchkiss, Pamela Norberg, et al. · The Journal of Immunology
PDF
Abstract 6477: Peptide-based tumor-associated antigen vaccine in glioblastoma: Correlative results of the ETAPA Phase I clinical trial
2026 · Elizabeth Owens, Kelly M. Hotchkiss, et al. · Cancer Research
Clinical trial of feasibility for mindfulness intervention for patients with newly diagnosed high grade glioma
2025 · Kavya Ramamurthy, Dina M. Randazzo, et al. · Journal of Neuro-Oncology
PDF
TIP-25. Randomized phase 2 clinical trial of repeated intratumoral and cervical perilymphatic injections (CPLIs) of lerapolturev vs. lomustine in recurrent glioblastoma (rGBM): safety lead-in results
2025 · Madison L Shoaf, Matthias Gromeier, et al. · Neuro-Oncology
PDF
Os04.3.a P30-eps Peptide Vaccine Is Safe and Immunogenic in Newly Diagnosed Glioblastoma: a Phase 1b Trial
2025 · K M Hotchkiss, P Norberg, et al. · Neuro-Oncology
PDF
BIOM-04. Immune correlates from a Phase 1 trial of a peptide vaccine targeting CMV antigen pp65 in children and young adults with recurrent high-grade glioma
2025 · Eric Thompson, Katayoun Ayasoufi, et al. · Neuro-Oncology Pediatrics
Abstract CT057: Evaluation of tumor associated P30-peptide antigen (ETAPA): Safety and immunogenicity in a phase 1b trial in glioblastoma
2025 · Kelly Hotchkiss, Pamela Norberg, et al. · Cancer Research
A surgical window of opportunity trial evaluating the effect of the PCSK9 inhibitor evolocumab on tumoral MHC-I expression and CD8+ infiltration in glioma
2025 · Mustafa Khasraw, Kirit Singh, et al. · Research Square
PDF
Ctim-01. Outcomes and Immune Responses After Peptide Vaccination Targeting Human Cytomegalovirus Antigen Pp65 in Children and Young Adults With Recurrent High-grade Glioma and Medulloblastoma: Results of a Phase 1 Trial
2024 · Eric Thompson, David Ashley, et al. · Neuro-Oncology
PDF
Imun-04 Combining Checkpoint Blockade and Laser Ablation for Progressive Non-small Cell Lung Cancer Brain Metastases
2024 · Aden Haskell-Mendoza, Ethan Srinivasan, et al. · Neuro-Oncology Advances
Works count: 28
Citation count: 155
H-index: 7
I10-index: 5
Year
Topic
Type